ADVANCED CELL DIAGNOSTICS AND LEICA BIOSYSTEMS BEGIN CO-MARKETING FULLY AUTOMATED RNA IN SITU HYBRIDIZATION ASSAY
August 13, 2014

ADVANCED CELL DIAGNOSTICS AND LEICA BIOSYSTEMS BEGIN CO-MARKETING FULLY AUTOMATED RNA IN SITU HYBRIDIZATION ASSAY

2014 August 13 | Posted by Quynh Doan

 

MELBOURNE, AUSTRALIA & HAYWARD, CALIFORNIA, August13, 2014–Leica Biosystems and Advanced Cell Diagnostics, Inc. (ACD) have announced the co-marketing of ACD's RNAscope® LS ISH assays with Leica Biosystems' BOND RX research staining platform*. This agreement provides researchers with an integrated and fully automated ISH solution. The market-leading RNAscope LS reagent kits and ISH probes are available from ACD while the BOND RX instrument and associated reagents are supplied by Leica Biosystems.

ACD's RNAscope assays represent a major technological advance forin situ RNA detection. For the first time,robust single RNA molecule detection is available for formalin-fixed, paraffin-embedded (FFPE) tissue. Since their commercialization three years ago, these assays have been adopted across the globe by major pharma biotech companies and leading research institutions for drug discovery, translational research, and the development of clinical and companion diagnostic tests. The RNAscope LS assays are fully automated on the BOND RX platform. This open and flexible system automates staining to provide a fast, high throughput workflow with exceptional consistency and minimal hands-on time.

"Automation is essential for pharmas, biotechs, translational labs and academic institutions to apply the RNA ISH technology to a wide range of biomarker analysis applications." said Dr. Yuling Luo, President and CEO of ACD. "We are very pleased to work with Leica Biosystems to expand our automated RNAscope solutions in response to the needs of our rapidly growing customer base."

Dr.David Atkins, VP Advanced Staining at Leica Biosystems added: “Leica is excited to announce the availability of ACD's RNAscope Assays fully automated on the BOND RX. This is another example of how,with its openness and flexibility, the BOND RX is providing researchers with enhanced tools to help speed-up important discoveries and improve cancer diagnostics".

*For Research Use Only. Not for use in diagnostic procedures.

Learn more about ACD at www.acdbio.com and about RNAscope(R) Automated Solutions at acdbio.com/products/automated-assays

Further information about Leica Biosytems can be found at www.LeicaBiosystems.com.

Contact
Media Contact –- ACD
Steve Chen, Ph.D., Chief Operating Officer,
schen@acdbio.com, +1 (510) 259-9802

X
Contact Us

Complete one of the two forms below and we will get back to you.

Advanced Cell Diagnostics

Our new headquarters office starting May 2016:

7707 Gateway Blvd.  
Newark, CA 94560
Toll Free: 1 (877) 576-3636
Phone: (510) 576-8800
Fax: (510) 576-8798

 

Advanced Cell Diagnostics , S.r.l.

Via Calabria15
20090 Segrate (Milano) - Italy

Phone: +39.02.95360323
Fax: +39.02.95360992
For European orders: order_europe@acdbio.com

Advanced Cell Diagnostics China

Building 15, No. 26 Xihuan South Road
Beijing Economic-Technological Development Area
Beijing, China, Zip code: 100176

400-966-1796
info_china@acdbio.com
For general information: Leon Li lli@acdbio.com
Web: www.acdbio.com.cn

For general information: info@acdbio.com
For place an order: order@acdbio.com
For product support: support@acdbio.com
For career opportunities: hr@acdbio.com